View in EDS HTML Full Text PDF Full Text

Cost-effectiveness of de-escalated molecular subtype dependent use of neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer in a Swedish setting.

Saved in:
Bibliographic Details
Title: Cost-effectiveness of de-escalated molecular subtype dependent use of neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer in a Swedish setting.
Authors: Saha S; Health Economics Unit, Department of Clinical Sciences (Malmö), Lund University, Lund, Sweden., Gerdtham UG; Health Economics Unit, Department of Clinical Sciences (Malmö), Lund University, Lund, Sweden.; Department of Economics, Lund University, Lund, Sweden., Sjödahl G; Division of Clinical and Experimental Urothelial Carcinoma Research, Department of Translational Medicine, Lund University, Malmö, Sweden.; Department of Urology, Skåne University Hospital, Malmö, Sweden., Häggström C; Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.; Northern Registry Centre, Department of Diagnostic and Intervention, Umeå University, Umeå, Sweden., Catto JWF; Division of Clinical Medicine, School of Medicine & Population Health, University of Sheffield, Sheffield, United Kingdom., Kelly JD; Division of Surgery & Interventional Science, University College London, London, United Kingdom., Ullén A; Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden.; Department of Pelvic Cancer, Genitourinary Oncology and Urology Unit, Karolinska University Hospital, Stockholm, Sweden., Holmberg L; Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.; Division of Cancer Studies, Medical School, King's College London, London, United Kingdom., Liedberg F; Division of Clinical and Experimental Urothelial Carcinoma Research, Department of Translational Medicine, Lund University, Malmö, Sweden.; Department of Urology, Skåne University Hospital, Malmö, Sweden.
Source: Frontiers in oncology [Front Oncol] 2025 Apr 02; Vol. 15, pp. 1556881. Date of Electronic Publication: 2025 Apr 02 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40242238
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Cost-effectiveness of de-escalated molecular subtype dependent use of neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer in a Swedish setting.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Saha+S%22">Saha S</searchLink>; Health Economics Unit, Department of Clinical Sciences (Malmö), Lund University, Lund, Sweden.<br /><searchLink fieldCode="AU" term="%22Gerdtham+UG%22">Gerdtham UG</searchLink>; Health Economics Unit, Department of Clinical Sciences (Malmö), Lund University, Lund, Sweden.; Department of Economics, Lund University, Lund, Sweden.<br /><searchLink fieldCode="AU" term="%22Sjödahl+G%22">Sjödahl G</searchLink>; Division of Clinical and Experimental Urothelial Carcinoma Research, Department of Translational Medicine, Lund University, Malmö, Sweden.; Department of Urology, Skåne University Hospital, Malmö, Sweden.<br /><searchLink fieldCode="AU" term="%22Häggström+C%22">Häggström C</searchLink>; Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.; Northern Registry Centre, Department of Diagnostic and Intervention, Umeå University, Umeå, Sweden.<br /><searchLink fieldCode="AU" term="%22Catto+JWF%22">Catto JWF</searchLink>; Division of Clinical Medicine, School of Medicine & Population Health, University of Sheffield, Sheffield, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Kelly+JD%22">Kelly JD</searchLink>; Division of Surgery & Interventional Science, University College London, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Ullén+A%22">Ullén A</searchLink>; Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden.; Department of Pelvic Cancer, Genitourinary Oncology and Urology Unit, Karolinska University Hospital, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Holmberg+L%22">Holmberg L</searchLink>; Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.; Division of Cancer Studies, Medical School, King's College London, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Liedberg+F%22">Liedberg F</searchLink>; Division of Clinical and Experimental Urothelial Carcinoma Research, Department of Translational Medicine, Lund University, Malmö, Sweden.; Department of Urology, Skåne University Hospital, Malmö, Sweden.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2025 Apr 02; Vol. 15, pp. 1556881. <i>Date of Electronic Publication: </i>2025 Apr 02 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40242238
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fonc.2025.1556881
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1556881
    Titles:
      – TitleFull: Cost-effectiveness of de-escalated molecular subtype dependent use of neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer in a Swedish setting.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Saha S
      – PersonEntity:
          Name:
            NameFull: Gerdtham UG
      – PersonEntity:
          Name:
            NameFull: Sjödahl G
      – PersonEntity:
          Name:
            NameFull: Häggström C
      – PersonEntity:
          Name:
            NameFull: Catto JWF
      – PersonEntity:
          Name:
            NameFull: Kelly JD
      – PersonEntity:
          Name:
            NameFull: Ullén A
      – PersonEntity:
          Name:
            NameFull: Holmberg L
      – PersonEntity:
          Name:
            NameFull: Liedberg F
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 04
              Text: 2025 Apr 02
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 2234-943X
          Numbering:
            – Type: volume
              Value: 15
          Titles:
            – TitleFull: Frontiers in oncology
              Type: main
ResultId 1